[Enoxacin concentration in bone tissue]. 1989

D Adam, and K Weismeier, and F Sörgel, and J Zürcher
Abteilung für antimikrobielle Therapie und Infektionsimmunologie, Universitäts-Kinderklinik, München.

For successful treatment of bacterial osteomyelitis the administered antibiotic must reach sufficiently high concentrations in bone tissues. Therefore concentrations of enoxacin in bone in ten patients requiring hip surgery were measured. To prevent a postoperative infection, 400 mg enoxacin b.i.d. for two days were administered. On an average 120 (90-210) min after the final dose samples of venous blood and bone tissue were taken. The bone pieces were divided into corticalis and spongiosa. Using a bio-assay-method the following concentrations were found: (mean +/- S.D.): serum 2.88 ( +/- 0.90) mg/l, corticalis 5.90 ( +/- 0.79) mg/kg, spongiosa 3.95 ( +/- 1.01) mg/kg. Thus enoxacin reaches higher levels in bone tissue than in serum.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D005260 Female Females
D006622 Hip Prosthesis Replacement for a hip joint. Femoral Head Prosthesis,Femoral Head Prostheses,Hip Prostheses,Prostheses, Femoral Head,Prostheses, Hip,Prosthesis, Femoral Head,Prosthesis, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013530 Surgical Wound Infection Infection occurring at the site of a surgical incision. Postoperative Wound Infection,Infection, Postoperative Wound,Infection, Surgical Wound,Surgical Site Infection,Wound Infection, Postoperative,Wound Infection, Surgical,Infection, Surgical Site,Infections, Postoperative Wound,Infections, Surgical Site,Infections, Surgical Wound,Postoperative Wound Infections,Surgical Site Infections,Surgical Wound Infections,Wound Infections, Postoperative,Wound Infections, Surgical
D015365 Enoxacin A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. AT-2266,CI-919,Enoxacin Sesquihydrate,Enoxin,Enoxor,PD-107779,Penetrex,AT 2266,AT2266,CI 919,CI919,PD 107779,PD107779,Sesquihydrate, Enoxacin

Related Publications

D Adam, and K Weismeier, and F Sörgel, and J Zürcher
October 1986, Hinyokika kiyo. Acta urologica Japonica,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
January 1986, The Journal of antimicrobial chemotherapy,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
January 1990, Hinyokika kiyo. Acta urologica Japonica,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
July 1988, Hinyokika kiyo. Acta urologica Japonica,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
August 1988, Hinyokika kiyo. Acta urologica Japonica,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
January 1989, Infection,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
July 1989, Journal of chemotherapy (Florence, Italy),
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
April 1993, Aktuelle Traumatologie,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
January 1989, The Journal of antimicrobial chemotherapy,
D Adam, and K Weismeier, and F Sörgel, and J Zürcher
July 1984, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!